All In Biotech

Drug Trial Radar · NCT00911508

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Last checked: Nov 19, 2026Latest source record: Apr 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,204 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,204

Actual

Start

Nov 13, 2009

Primary completion

Dec 31, 2017

Study completion Dec 31, 2017

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Abbott Medical Devices; Biosense Webster, Inc.
First posted
Jun 2, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The (Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial) CABANA Trial has the overall goal of establishing the appropriate roles for medical and ablative intervention for atrial fibrillation (AF). The CABANA Trial is designed to test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) will be superior to current state-of-the-art therapy with either rate control or rhythm control drugs for decreasing the incidence of the composite endpoint of total mortality, disabling stroke, serious bleeding, or cardiac arrest in patients with untreated or incompletely treated AF.

Conditions

  • Atrial Fibrillation
  • Arrhythmia

Interventions

  • Left atrial ablationDevice

    St. Jude: Livewire TC™ , Therapy™ Dual / Thermocouple, Safire,Therapy Cool Path Biosense Webster: NAVI-STAR, NAVI-STAR/NAVI-STAR DS, Celsius Braided/Long Tip, NAVI-STAR™ and Celsius™ ThermoCool, NAVI-STAR® RMT, Celsius® RMT, ThermoCool® SF Medtronic CryoCath LP: Freezor®/Freezor MAX®, Artic Front®, Cardiac Ablation System Bard: Stinger Boston Scientific: Blazer II RF/XP, Blazer RPM, Chilli II Cooled, SteeroCath

  • Rate or Rhythm Control TherapyDrug

    Rate control: Metoprolol 50-100mg, Atenolol 50-100mg, Propranolol 40-80mg, Acebutolol 200-300mg, Carvedilol 6.25-25mg, Diltiazem 180-240mg, Verapamil 180-240mg, Digoxin 0.125-0.25mg Rhythm control: Propafenone 450-625mg, Flecainide 200-300mg, Sotalol 240-320mg, Dofetilide 500-1000mcg, Amiodarone 200-400mg, Quinidine 600-900mg, Dronedarone 800mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Composite of Total Mortality, Disabling Stroke, Serious Bleeding, or Cardiac Arrest in Patients Warranting Therapy for AF.Time frame: From date of enrollment until time-to-first event over a median follow-up of 48.5 months.

Locations

118 sites in 10 countries. Site status is shown where the registry gives one.

  • Arkansas Cardiology, PA

    Little Rock, Arkansas

  • Good Samaritan Hospital

    Los Angeles, California

  • University of California Los Angeles

    Los Angeles, California

  • University of California Davis Medical Center

    Sacramento, California

  • University of California at San Francisco Medical Center

    San Francisco, California

  • Stanford University Medical Center

    Stanford, California

  • The Medical Center of Aurora

    Aurora, Colorado

  • Penrose Saint Francis Health Services

    Colorado Springs, Colorado

  • Hartford Hospital

    Hartford, Connecticut

  • George Washington University Medical Faculty Associates

    Washington D.C., District of Columbia

  • University of Miami Hospital

    Miami, Florida

  • Florida Hospital

    Orlando, Florida

  • Northside Hospital and Heart Institute

    St. Petersburg, Florida

  • Tallahassee Memorial Hospital

    Tallahassee, Florida

  • Florida Heart Rhythm-University of South Florida College of Medicine

    Tampa, Florida

  • Georgia Regents University

    Augusta, Georgia

  • Georgia Arrhythmia Consultants & Research Institute

    Macon, Georgia

  • Alexian Brothers Medical Center

    Barrington, Illinois

  • Rush University Medical Center

    Chicago, Illinois

  • NorthShore University Health System

    Evanston, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • Mercy Medical Center-Iowa Heart Center

    West Des Moines, Iowa

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Brigham and Womens Hospital

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Saint Joseph Mercy Hospital

    Ypsilanti, Michigan

  • Minneapolis V.A. Medical Center

    Minneapolis, Minnesota

  • Mayo Clinic Rochester

    Rochester, Minnesota

  • Park Nicollet Methodist Hospital

    Saint Louis Park, Minnesota

  • Jackson Heart Clinic

    Jackson, Mississippi

  • Saint John's Mercy Heart Health Center

    St Louis, Missouri

  • Saint Louis Heart and Vascular

    St Louis, Missouri

  • Cooper University Hospital

    Camden, New Jersey

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Robert Wood Johnson University Hospital

    New Brunswick, New Jersey

  • Albany Associates in Cardiology

    Albany, New York

  • New York University Langone Medical Center

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • Stony Brook University Hospital and Medical Center

    Stony Brook, New York

Showing 40 of 118 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.